DFSVX
Price
$48.80
Change
-$0.45 (-0.91%)
Updated
Aug 15 closing price
Net Assets
16.21B
RYYCX
Price
$170.18
Change
-$0.93 (-0.54%)
Updated
Aug 15 closing price
Net Assets
6.89M
Interact to see
Advertisement

DFSVX vs RYYCX

Header iconDFSVX vs RYYCX Comparison
Open Charts DFSVX vs RYYCXBanner chart's image
DFA US Small Cap Value I
Price$48.80
Change-$0.45 (-0.91%)
VolumeN/A
Net Assets16.21B
Rydex S&P SmallCap 600 Pure Value C
Price$170.18
Change-$0.93 (-0.54%)
VolumeN/A
Net Assets6.89M
DFSVX vs RYYCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DFSVX vs. RYYCX commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFSVX is a Buy and RYYCX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFSVX has more cash in the bank: 16.2B vs. RYYCX (6.89M). DFSVX pays higher dividends than RYYCX: DFSVX (1.64) vs RYYCX (0.00). DFSVX was incepted earlier than RYYCX: DFSVX (32 years) vs RYYCX (22 years). RYYCX (2.35) is less costly to investors than DFSVX (0.31). RYYCX is a more actively managed with annual turnover of: 1587.00 vs. DFSVX (12.00). DFSVX has a lower initial minimum investment than RYYCX: DFSVX (0) vs RYYCX (2500). RYYCX annual gain was more profitable for investors over the last year : 6.39 vs. DFSVX (5.62). RYYCX return over 5 years is better than : 92.38 vs. DFSVX (80.15).
DFSVXRYYCXDFSVX / RYYCX
Total Expense Ratio0.312.3213%
Annual Report Gross Expense Ratio0.312.3513%
Fund Existence32 years22 years-
Gain YTD1.4830.974152%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets16.2B6.89M234,987%
Annual Yield % from dividends1.640.00-
Returns for 1 year5.626.3988%
Returns for 3 years16.0916.2799%
Returns for 5 years80.1592.3887%
Returns for 10 years50.6364.6078%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RAPT11.740.49
+4.36%
RAPT Therapeutics Inc
CORZ14.130.30
+2.13%
Core Scientific
KLC7.500.11
+1.49%
KinderCare Learning Companies Inc
GDTC1.800.02
+0.90%
CytoMed Therapeutics Limited
CBRE158.930.39
+0.25%
Cbre Group